Satcon and GCL Solar Sign Production Agreement

Satcon Technology Corporation, a supplier of utility scale solar power solutions, has declared the signing of a production agreement with GCL Solar Systems Limited, a utility level solar plant developer in China to increase the manufacturing capability of their 500 kilowatt (kW) PowerGate Plus line of solar PV inverters for  use in Asia Pacific solar market.

The signed agreement requires GCL Solar to start a production facility in Nanjing Province China to manufacture more than 500 MW worth of 500 kW PowerGate Plus inverters by the year 2011. Satcon will be required to offer GCL Solar with the details of its production process and technology for the manufacture of PowerGate Plus for assembling at the solar plant of GCL. The agreement requires GCL Solar to purchase from Satcon the capability to manufacture a minimum of 300 MW every year from its Nanjing facility. GCL Solar needs to sell the PowerGate Plus 500 kW inverters produced at the Nanjing production facility in the Chinese market and to use it in its funded developments all over the world. The production from the Nanjing facility is anticipated to start by March 2011 and when this is aggregated with the augmented production operations at Burlington, Ontario will increase its annual production value to 2 GW.

Steve Rhoades, Satcon’s CEO, said that the two partnering companies have supplied their products to some of the most developed solar installations and each such installation demonstrates the system value the partnership can contribute to the utility level solar market. He added that the mix of GCL’s product design,building expertise and the advanced technology of his company helped them to offer superior level of dependability and system value to its clients. He concluded that the developed technological partnership with GCL will allow both the companies to efficiently tackle the growing demand for offering large scale solutions collectively.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.